Underdiagnosis of depression in HIV
Who are we missing?
Cite this article as: Asch, S.M., Kilbourne, A.M., Gifford, A.L. et al. J GEN INTERN MED (2003) 18: 450. doi:10.1046/j.1525-1497.2003.20938.x Abstract OBJECTIVE: To determine the sociodemographic and service delivery correlates of depression underdiagnosis in HIV. DESIGN: Cross-sectional survey. PATIENTS/PARTICIPANTS: National probability sample of HIV-infected persons in care in the contiguous United States who have available medical record data. MEASUREMENTS AND MAIN RESULTS: We interviewed patients using the Composite International Diagnostic Interview (CIDI) survey from the Mental Health Supplement. Patients also provided information regarding demographics, socioeconomic status, and HIV disease severity. We extracted patient medical record data between July 1995 and December 1997, and we defined depression underdiagnosis as a diagnosis of major depressive disorder based on the CIDI and no recorded depression diagnosis by their principal health care provider in their medical records between July 1995 and December 1997. Of the 1,140 HIV Cost and Services Utilization Study patients with medical record data who completed the CIDI, 448 (37%) had CIDI-defined major depression, and of these, 203 (45%) did not have a diagnosis of depression documented in their medical record. Multiple logistic regression analysis revealed that patients who had less than a high school education ( P<.05) were less likely to have their depression documented in the medical record compared to those with at least a college education. Patients with Medicare insurance coverage compared to those with private health insurance ( P<.01) and those with ≥3 outpatient visits ( P<.05) compared to <3 visits were less likely to have their depression diagnosis missed by providers. CONCLUSIONS: Our results suggest that providers should be more attentive to diagnosing comorbid depression in HIV-infected patients. Key words depression HIV diagnosis
The HIV Cost and Services Utilization Study is being conducted under cooperative agreement U-01HS08578 (M. F. Shapiro, Pl; S. A. Bozzette, Co-Pl) between RAND and the Agency for Healthcare Research and Quality (AHRQ, formerly the Agency for Health Care Policy and Research). Substantial additional funding for this cooperative agreement was provided by the Health Resources and Services Administration, the National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institutes of Health Office of Research on Minority Health through the National Institute of Dental Research. Additional support was provided by VA HSR&D Career Development Awards (Dr. Asch and Dr. Kilbourne), the Robert Wood Johnson Foundation, Merck and Company, Glaxo-Wellcome, Inc., the National Institute on Aging, and the Office of the Assistant Secretary for Planning and Evaluation in the U.S. Department of Health and Human Services. Drs. Bozzette and Asch are Health Services Research and Development Senior Research Associates of the Department of Veterans’ Affairs.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.
Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996;93:1976–80.
Masand PS, Kaplan DS, Gupta S, et al. Major depression and irritable bowel syndrome: is there a relationship? J Clin Psychiatry. 1995;56:363–7.
Roose SP, Glassman AH, Seidman SN. Relationship between depression and other medical illnesses. JAMA. 2001;286:1687–90.
Sherbourne CD, Wells KB, Hays RD, Rogers W, Burnam MA, Judd LL. Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health specialty outpatients. Am J Psychiatry. 151:1777–84.
Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–8.
Kilbourne AM, Justice AC, Rabeneck L, Rodriguez-Barradas M, Weissman S. General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol. 2001;54(suppl 1):22–8.
Lyketsos CG, Hutton H, Fishman M, Schwartz J, Treisman GJ. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS. 1996;10:1033–9.
Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725–30.
Dew MA, Becket JT, Sanchez J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV infected and uninfected men: a longitudinal evaluation. Psychol Med. 1997;27:395–409.
Kelly B, Raphael B, Judd F, et al. Psychiatric disorders in HIV infection. Aust N Z J Psychiatry. 1998;32:441–53.
Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466–74.
Leserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61:397–406.
Katon W. The epidemiology of depression in medical care. Int J Psychiatry Med. 1987;17:93–112.
Wells KB, Norquist G, Benjamin B, Rogers W, Kahn K, Brook R. Quality of antidepressant medications prescribed at discharge to depressed elderly patients in general medical hospitals before and after prospective payment system. Gen Hosp Psychiatry. 1994;16:4–15.
Schulberg HC, Block MR, Madonia MJ, et al. The usual care of major depression in primary care practice. Arch Fam Med. 1997;6:334–9.
Perez-Stable E, Miranda J, Munoz R, Ying Y. Depression in medical outpatients: under-recognition and misdiagnosis. Arch Intern Med. 1990;150:1083–88.
Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late life. Consensus statement update. JAMA. 1997;278:1186–90.
Alexopoulos GS, Vrontou C, Kakuma T, et al. Disability in geriatric depression. Am J Psychiatry. 1996;153:877–85.
Koenig HG, George LK, Larson DB, McCullough ME, Branch PS, Kuchibhatla M. Depressive symptoms and nine-year survival of 1,001 male veterans hospitalized with medical illness. Am J Geriatr Psychiatry. 1999;7:124–31.
Fiscella K, Franks P, Doescher MP, Saver BG. Disparities in health care by race, ethnicity, and language among the insured: findings from a national sample. Med Care. 2002;40:52–9.
Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14:569–80.
Singh N, Squier C, Sivek C, et al. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8:261–9.
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–7.
Hays RD, Kravitz RL, Mazel RM, et al. The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. J Behav Med. 1994;17:347–60.
Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278–85.
Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary disease. Health Psychol. 1995;14:88–90.
Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J. 1995;8:899–904.
Wenger N, Gifford A, Lui H, et al. Patient characteristics and attitudes associated with antiretroviral adherence. In: Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago, Ill: January 31–February 4, 1999; Abstract ’98.
Cook RL, Hunt S, Woodward C, et al. Problem drinking and adherence to HIV therapy. J Gen Intern Med. 1999;14(suppl 2):93.
Frankel MR, Shapiro MF, Duan N, et al. National probability samples in studies of low-prevalence diseases, Part II: designing and implementing the HIV Cost and Services Utilization Study Sample. Health Serv Res. 1999;34:969–92.
Shapiro MF, Berk ML, Berry SH, et al. National probability samples in studies of low-prevalence diseases, Part 1: perspectives and lessons learned from the HIV Cost and Services Utilization Study. Health Serv Res. 1999;34:951–68.
Kessler RC, Andrews G, Mroczek D, Ustun B, Wittchen H. The World Health Organization Composite International Diagnostic Interview Short Form (CIDI-SF). Int J Methods Psychiatr Res. 1998;7:171–85.
Orlando M, Burnam MA, London AS, et al. Brief screening of psychiatric disorders among a national sample of HIV-positive adults: concordance between the Composite International Diagnostic Interview (CIDI) and the CIDI short form (CIDI-SF). Int J Methods Psychiatr Res. 2001;10:97–107.
Robins LN, Wing J, Wittchen HU, et al. The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45:1069–77.
Kilbourne AM, Andersen RM, Asch S, et al. Response to symptoms among a U.S. national probability sample of adults infected with human immunodeficiency virus. Med Care Res Rev. 2002;59:36–58.
Andersen R, Bozzette S, Shapiro M, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HIV Cost and Services Utilization Study. Health Serv Res. 2000;35:389–416.
Williams JW Jr, Noel PH, Cordes JA, Ramirez G, Pignone M. Is this patient clinically depressed? JAMA. 2002;287:1160–70.
Coyne JC, Fechner-Bates S, Schwenk TL. Prevalence, nature, and comorbidity of depressive disorders in primary care. Gen Hosp Psychiatry. 1994;16:267–76.
Whyte EM, Mulsant BH. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry. 2002;52:253–64.
Burg MM, Abrams D. Depression in chronic medical illness: the case of coronary heart disease. J Clin Psychol. 2001;57:1323–37.
Leopold KA, Ahles TA, Walch S, et al. Prevalence of mood disorders and utility of the PRIME-MD in patients undergoing radiation therapy. Int J Radiat Oncol Biol Phys. 1998;42:1105–12.
Goldney RD, Fisher LJ, Wilson DH. Mental health literacy: an impediment to the optimum treatment of major depression in the community. J Affect Disord. 2001;64:277–84.
Lin E, Parikh SV. Sociodemographic, clinical, and attitudinal characteristics of the untreated depressed in Ontario. J Affect Disord. 1999;53:153–62.
Goldman DP, Smith JP. Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci USA. 2002;99:10929–34.
Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14:267–73.
Rost K, Smith R, Matthews DB, Guise B. The deliberate misdiagnosis of major depression in primary care. Arch Fam Med. 1994;3:333–7.
Conwell Y, Suicide in the elderly. In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff AJ, eds. Diagnosis and Treatment of Depression in Late Life. Results of the NIMH Consensus Development Conference. Washington, DC: American Psychiatric Press; 1994;397–418.
Katz MH, Douglas JM Jr, Bolan GA, et al. Depression and use of mental health services among HIV-infected men. AIDS Care. 1996;8:433–42.
Fleishman JA, Hsia DC, Hellinger FJ. Correlates of medical service utilization among people with HIV infection. Health Serv Res. 1994;29:527–48.
Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58:729–36.
National Institute of Mental Health. The Unwanted Co-traveler: Depression’s Toll on Other Illnesses. HIV and Depression Fact Sheet. Bethesda, Md: National Institute of Mental Health; 2000.
Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516–20.
Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John’s Wort. Lancet. 2000;355:547–8.
Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:765–76.
Rabkin JG, Wagner GJ, Rabkin R. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Am J Psychiatry. 1999;156:101–7.
Markowitz JC, Klerman GL, Clougherty KF, et al. Individual psychotherapies for depressed HIV-positive patients. Am J Psychiatry. 1995;152:1504–9.
Gill D, Hatcher S. A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness. In: The COCHRANE Database. London, UK: Department of Liaison Psychiatry, Whipps Cross Hospital; 1999.
Ferrando SJ, Goldman JD, Charness WE. Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms. Gen Hosp Psychiatry. 1997;19:89–97.
PubMed CrossRef Copyright information
© Society of General Internal Medicine 2003